BCRX icon

BioCryst Pharmaceuticals

123 hedge funds and large institutions have $938M invested in BioCryst Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 41 increasing their positions, 27 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
123
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9.82M
Puts
$10.8M
Net Calls
Net Calls Change

Top Buyers

1 +$16.4M
2 +$11.3M
3 +$11.2M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$8.18M
5
PA
Perceptive Advisors
New York
+$7.02M

Top Sellers

1 -$64.5M
2 -$20.5M
3 -$18M
4
Millennium Management
Millennium Management
New York
-$7.68M
5
AQR Capital Management
AQR Capital Management
Connecticut
-$3.08M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$173M
2
$144M
3
$104M
4
$47.9M
5
$42.2M
6
$38.9M
7
$36.9M
8
$33.8M
9
$32.4M
10
$28.6M
11
$27.2M
12
$19.7M
13
$17.5M
14
$15.4M
15
$12.2M
16
$11.9M
17
$11.2M
18
$10.2M
19
$8.18M
20
$7.02M
21
$6.06M
22
$5.85M
23
$5.58M
24
$5.38M
25
$5.24M